Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lundstrom

Showing results (11-20 of 506) with videos related to

Pageof 51
Sort By:
Diseases (Basel, Switzerland)|May 1, 2019
Gene Therapy Today and TomorrowKenneth Lundstrom
Current Drug Discovery Technologies|April 26, 2011
Micro-RNA in disease and gene therapyKenneth Lundstrom
Biologics : Targets & Therapy|February 16, 2018
New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacyKenneth Lundstrom
Journal of Cellular and Molecular Medicine|May 10, 2007
Structural genomics and drug discoveryK Lundstrom
Vaccines|November 10, 2016
Replicon RNA Viral Vectors as VaccinesKenneth Lundstrom
Expert Opinion on Drug Discovery|March 10, 2017
Cell-impedance-based label-free technology for the identification of new drugsKenneth Lundstrom
Vaccines|April 19, 2017
Oncolytic Alphaviruses in Cancer ImmunotherapyKenneth Lundstrom
Methods in Molecular Biology (Clifton, N.J.)|January 26, 2010
Expression of mammalian membrane proteins in mammalian cells using Semliki Forest virus vectorsKenneth Lundstrom
Viruses|February 24, 2024
COVID-19 Vaccines: Where Did We Stand at the End of 2023?Kenneth Lundstrom
Cold Spring Harbor Protocols|July 4, 2012
Determination of alphaviral titersKenneth Lundstrom
Pageof 51

Showing results (11-20 of 506) with videos related to

Sort By:
Pageof 51
Diseases (Basel, Switzerland)|May 1, 2019
Gene Therapy Today and TomorrowKenneth Lundstrom
Current Drug Discovery Technologies|April 26, 2011
Micro-RNA in disease and gene therapyKenneth Lundstrom
Biologics : Targets & Therapy|February 16, 2018
New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacyKenneth Lundstrom
Journal of Cellular and Molecular Medicine|May 10, 2007
Structural genomics and drug discoveryK Lundstrom
Vaccines|November 10, 2016
Replicon RNA Viral Vectors as VaccinesKenneth Lundstrom
Expert Opinion on Drug Discovery|March 10, 2017
Cell-impedance-based label-free technology for the identification of new drugsKenneth Lundstrom
Vaccines|April 19, 2017
Oncolytic Alphaviruses in Cancer ImmunotherapyKenneth Lundstrom
Methods in Molecular Biology (Clifton, N.J.)|January 26, 2010
Expression of mammalian membrane proteins in mammalian cells using Semliki Forest virus vectorsKenneth Lundstrom
Viruses|February 24, 2024
COVID-19 Vaccines: Where Did We Stand at the End of 2023?Kenneth Lundstrom
Cold Spring Harbor Protocols|July 4, 2012
Determination of alphaviral titersKenneth Lundstrom
Pageof 51